The Netherlands
Batavia Biosciences is a biotechnology company based in The Netherlands, founded in 2010. Its slogan, "Accelerate Biotechnology," reflects its dedication to speeding up the biopharmaceutical development process. The company functions as a science-based CDMO, offering personalized services that cover all stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. While it operates as a CDMO, it distinguishes itself by being perceived as a product development partner and thought partner by its customers.
Batavia Biosciences' services are primarily centered around the early stages of product development, including DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization, and clinical manufacturing. The company's last investment occurred on 09 April 2024 and was a grant investment from the National Institute for Innovation in Manufacturing Biopharmaceuticals.
Headquartered in Leiden, The Netherlands, Batavia Biosciences enjoys the support of strong strategic partners in both the EU and US. With a mission to significantly contribute to easing human suffering from infectious disease and cancer, the company is positioned at the forefront of biotechnology, aiming to have a substantial impact on healthcare.
Pyramid Labs